Impact of Social Determinants of Health on Access to Device Aided Therapy Services for Medicare Fee-for-Service Beneficiaries with Advanced Parkinsons Disease


Teigland C1, Silverstein A1, Schinkel J2, Yan CH3
1Inovalon, Bowie, MD, USA, 2Inovalon, Ashburn, VA, USA, 3AbbVie Inc., North Chicago, IL, USA

Presentation Documents


Parkinson’s disease (PD) is a slowly progressive neurodegenerative disorder with treatments focused on symptom management. Despite efficacy of surgical device-aided therapies (DAT) to manage advanced PD (APD) symptoms, access may be limited due to barriers related to social determinants of health (SDOH). This study examined APD patient characteristics including near-neighborhood-level SDOH based on residence 9-digit ZIP-code to understand the impact of SDOH on DAT receipt.


100% Medicare Fee-for-Service claims data were utilized to identify adults with APD: ≥1 inpatient or ≥2 outpatient claims with a PD diagnosis 2018-2020 followed by occurrence of a treatment-related APD indicator. Demographic characteristics, SDOH, and distance between patient residence and facility were described for DAT recipients.


Among 503,245 beneficiaries with PD, 112,773 were APD (22%), 2.17% of whom received DAT at 416 facilities. DAT recipients were younger (mean age 71 vs. 76) and more often male (65% vs. 34%) than those who did not receive DAT. Black patients were 3x less likely and Hispanic patients 1.3x more likely to receive DAT than White patients. Dual eligible for Medicaid (i.e., low income) patients were 2.1x less likely than non-duals, while those who qualified for Medicare age <65 due to disability were 1.8x more likely to receive DAT. No difference in receiving DAT by urban vs. rural location was observed. APD patients who received DAT had higher household income ($72,220 vs. $71,048; p=0.0050) and were less likely to have completed high school education or less (34.7% vs. 35.9%; p=0.0010). APD patients with no vehicle were less likely to receive DAT (6.3% vs. 7.1%; p=0.0001).

CONCLUSIONS: The proportion of APD patients who receive DAT varies by race/ethnicity, income, disability status, education level, and vehicle ownership. These factors may contribute to access issues resulting in health disparities for APD patients who may benefit from DAT.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)




Health Policy & Regulatory

Topic Subcategory

Health Disparities & Equity


Neurological Disorders, No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now